BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 23852704)

  • 1. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update.
    Duffy MJ; Lamerz R; Haglund C; Nicolini A; Kalousová M; Holubec L; Sturgeon C
    Int J Cancer; 2014 Jun; 134(11):2513-22. PubMed ID: 23852704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
    Locker GY; Hamilton S; Harris J; Jessup JM; Kemeny N; Macdonald JS; Somerfield MR; Hayes DF; Bast RC;
    J Clin Oncol; 2006 Nov; 24(33):5313-27. PubMed ID: 17060676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.
    Nagasaka T; Tanaka N; Cullings HM; Sun DS; Sasamoto H; Uchida T; Koi M; Nishida N; Naomoto Y; Boland CR; Matsubara N; Goel A
    J Natl Cancer Inst; 2009 Sep; 101(18):1244-58. PubMed ID: 19700653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.
    Duffy MJ; van Dalen A; Haglund C; Hansson L; Holinski-Feder E; Klapdor R; Lamerz R; Peltomaki P; Sturgeon C; Topolcan O
    Eur J Cancer; 2007 Jun; 43(9):1348-60. PubMed ID: 17512720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system.
    Su MC; Yuan RH; Lin CY; Jeng YM
    Mod Pathol; 2008 Nov; 21(11):1379-86. PubMed ID: 18552820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor markers in colorectal cancer].
    Menéndez-Sánchez P; Villarejo-Campos P; Padilla-Valverde D; Menéndez-Rubio JM; Rodríguez-Montes JA
    Cir Cir; 2013; 81(2):169-75. PubMed ID: 23522321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.
    Duffy MJ; van Dalen A; Haglund C; Hansson L; Klapdor R; Lamerz R; Nilsson O; Sturgeon C; Topolcan O
    Eur J Cancer; 2003 Apr; 39(6):718-27. PubMed ID: 12651195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of fecal calprotectin as a screening biomarker for gastrointestinal malignancies.
    Khoshbaten M; Pishahang P; Nouri M; Lashkari A; Alizadeh M; Rostami-Nejad M
    Asian Pac J Cancer Prev; 2014; 15(4):1667-70. PubMed ID: 24641386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
    Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
    Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of gastrointestinal stromal tumors and gastric adenocarcinomas.
    Yan Y; Li Z; Liu Y; Zhang L; Li J; Ji J
    Tumour Biol; 2013 Apr; 34(2):919-27. PubMed ID: 23283817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue.
    Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM
    Dig Dis Sci; 2017 Mar; 62(3):678-688. PubMed ID: 28044229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.
    Blandamura S; Alessandrini L; Bertorelle R; Simonato F; Guzzardo V; Valentini E; Angriman I; Fassina A
    Pathol Res Pract; 2014 Jun; 210(6):392-6. PubMed ID: 24674454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.
    Miettinen M; Wang ZF; Sarlomo-Rikala M; Osuch C; Rutkowski P; Lasota J
    Am J Surg Pathol; 2011 Nov; 35(11):1712-21. PubMed ID: 21997692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours.
    Wong NA; Wingate J; Gradhand E
    Histopathology; 2015 Sep; 67(3):378-85. PubMed ID: 25659413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of incidental gastrointestinal stromal tumours on patients undergoing resection of upper gastrointestinal neoplasms.
    Chan CH; Cools-Lartigue J; Marcus VA; Feldman LS; Ferri LE
    Can J Surg; 2012 Dec; 55(6):366-70. PubMed ID: 22992402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).
    Agaimy A; Otto C; Braun A; Geddert H; Schaefer IM; Haller F
    Int J Clin Exp Pathol; 2013; 6(9):1839-46. PubMed ID: 24040448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established and Potential Predictive Biomarkers in Gastrointestinal Cancer--c-Kit, Her2, Ras and Beyond.
    Koch C; Trojan J
    Digestion; 2015; 91(4):294-302. PubMed ID: 25924988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.